title: Blastic plasmacytoid dendritic cell neoplasm with acute myeloid leukemia successfully treated to a remission currently of 26 months duration.
authors.forename: Andreas
authors.initials: A
authors.lastname: Voelkl
authors.forename: Michael
authors.initials: M
authors.lastname: Flaig
authors.forename: Tim
authors.initials: T
authors.lastname: Roehnisch
authors.forename: Nurcan
authors.initials: N
authors.lastname: Alpay
authors.forename: Ralf
authors.initials: R
authors.lastname: Schmidmaier
authors.forename: Fuat
authors.initials: F
authors.lastname: Oduncu
mesh_terms: D000208:Acute Disease; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015704:CD4 Antigens / Q000032:analysis; D019002:CD56 Antigen / Q000032:analysis; D003713:Dendritic Cells / Q000378:metabolism / Q000473:pathology*; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D012074:Remission Induction; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015704:CD4 Antigens; D019002:CD56 Antigen